We are excited to announce the launch of the VICT3R Website, which is now live! This updated website is a key resource for the VICT3R community, featuring comprehensive details about the project, our goals, publications, the latest news, and training resources. It will be the central hub for all project-related information and updates. As coordinators of our project, we would like to take this opportunity
In this edition of Minds Behind VICT3R, we’re happy to feature Mathieu Vinken (Vrije Universiteit Brussel) – Partner at VICT3R, and Coordinator of both the ASPIS cluster and the ONTOX project. A huge thank you to Mathieu for sharing his expertise and perspectives with us. Don’t miss this opportunity to learn more about his role and contributions to our work!
We are thrilled to launch our new interview series, Minds Behind VICT3R, where we spotlight the talented individuals shaping the success of the VICT3R project. In our first edition, we’re excited to feature Claus Stie Kallesøe from grit42! Claus shares his background and sheds light on the pivotal role grit42 plays in advancing the project’s mission to reduce the use of animals in toxicology research.
We’re proud to announce that VICT3R is presented today at the 2nd Commission Conference on the Roadmap to phase out animal testing for chemical safety assessments held in Brussels. Hosted by the European Commission, this event brings together leading experts with the aim to accelerate the shift toward animal-free safety assessments, guided by the 3Rs – Replacement, Reduction, and Refinement. The Commission’s 3Rs Roadmap is
The VICT3R project kicked off with an inspiring meeting in Barcelona on 26-27 September 2024! With over 70 attendees in person and more than 50 joining online, the enthusiasm and commitment to this transformative project were palpable. From the outset, participants engaged in meaningful discussions and brought forward exciting proposals, setting a positive and proactive tone for the project's journey ahead. What made this meeting
This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172693.
The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe and Instem Scientific Limited.
Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.
© 2025 | VICT3R – Developing and implementing Virtual Control Groups to reduce animal use in Toxicology Research
